OCGN (STOCKS)
Ocugen, Inc. Common Stock
$1.760000
+0.000000 (+0.00%)
Prev close: $1.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Shankar Musunuri
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $585.30M
- Employees
- 95
- P/E (TTM)
- -7.93
- P/B (TTM)
- -45.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.06 | $-0.06 | -0.0008 | -1.35% |
|
Sep 2025 (Q3)
|
$-0.07 | $-0.06 | -0.0129 | -22.59% |
|
Jun 2025 (Q2)
|
$-0.05 | $-0.06 | +0.0087 | +14.82% |
|
Mar 2025 (Q1)
|
$-0.05 | $-0.06 | +0.0087 | +14.82% |
Financial Statements
| Revenues | $4.41M |
| Benefits Costs and Expenses | $72.26M |
| Costs And Expenses | $72.26M |
| Nonoperating Income/Loss | -$4.93M |
| Operating Expenses | $67.33M |
| Research and Development | $39.75M |
| Other Operating Expenses | $27.58M |
| Operating Income/Loss | -$62.92M |
| Income/Loss From Continuing Operations After Tax | -$67.85M |
| Income/Loss From Continuing Operations Before Tax | -$67.85M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$67.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$67.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$67.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $43.52M |
| Current Assets | $24.34M |
| Noncurrent Assets | $19.18M |
| Fixed Assets | $14.39M |
| Other Non-current Assets | $4.78M |
| Liabilities | $55.68M |
| Current Liabilities | $23.04M |
| Accounts Payable | $6.20M |
| Wages | $3.30M |
| Other Current Liabilities | $13.54M |
| Noncurrent Liabilities | $32.64M |
| Equity | -$12.17M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$12.17M |
| Liabilities And Equity | $43.52M |
| Net Cash Flow From Operating Activities | -$56.96M |
| Net Cash Flow From Operating Activities, Continuing | -$56.96M |
| Net Cash Flow From Investing Activities | -$311.00K |
| Net Cash Flow From Investing Activities, Continuing | -$311.00K |
| Net Cash Flow From Financing Activities | $17.33M |
| Net Cash Flow From Financing Activities, Continuing | $17.33M |
| Exchange Gains/Losses | $13.00K |
| Net Cash Flow | -$39.93M |
| Net Cash Flow, Continuing | -$39.95M |
| Comprehensive Income/Loss | -$67.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$67.83M |
| Other Comprehensive Income/Loss | $13.00K |